Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation

• Mohamed Abdel-Mohsen,

  Affiliations Blood Systems Research Institute, San Francisco, California, United States of America, University of California, San Francisco, California, United States of America

  ⨯
• Leonard Chavez,

  Affiliation Blood Systems Research Institute, San Francisco, California, United States of America

  ⨯
• Ravi Tandon,

  Affiliation School of Biotechnology, Jawaharlal Nehru University, New Delhi, India

  ⨯
• Glen M. Chew,

  Affiliation Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, United States of America

  ⨯
• Xutao Deng,

  Affiliation Blood Systems Research Institute, San Francisco, California, United States of America

  ⨯
• Ali Danesh,

  Affiliations Blood Systems Research Institute, San Francisco, California, United States of America, University of California, San Francisco, California, United States of America

  ⨯
• Sheila Keating,

  Affiliation Blood Systems Research Institute, San Francisco, California, United States of America

  ⨯
• Marion Lanteri,

  Affiliation Blood Systems Research Institute, San Francisco, California, United States of America

  ⨯
• Michael L. Samuels,

  Affiliation RainDance Technologies, Inc., Billerica, Massachusetts, United States of America

  ⨯
• Rebecca Hoh,

  Affiliation University of California, San Francisco, California, United States of America

  ⨯
• Jonah B. Sacha,

  Affiliations Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Philip J. Norris,

  Affiliations Blood Systems Research Institute, San Francisco, California, United States of America, University of California, San Francisco, California, United States of America

  ⨯
• Toshiro Niki,

  Affiliations GalPharma Co., Ltd., Takamatsu-shi, Kagawa, Japan, Department of Immunology and Immunopathology, Kagawa University, Kagawa, Japan

  ⨯
• Cecilia M. Shikuma,

  Affiliation Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, United States of America

  ⨯
• Mitsuomi Hirashima,

  Affiliations GalPharma Co., Ltd., Takamatsu-shi, Kagawa, Japan, Department of Immunology and Immunopathology, Kagawa University, Kagawa, Japan

  ⨯
• Steven G. Deeks,

  Affiliation University of California, San Francisco, California, United States of America

  ⨯
• Lishomwa C. Ndhlovu ,

  ¶‡ These authors are joint senior authors on this work.

  Affiliation Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, United States of America

  ⨯
•  [ ... ],
• Satish K. Pillai

  * E-mail: satish.pillai@ucsf.edu

  ¶‡ These authors are joint senior authors on this work.

  Affiliations Blood Systems Research Institute, San Francisco, California, United States of America, University of California, San Francisco, California, United States of America

  ⨯
• [ view all ]
• [ view less ]